Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study

Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study

Sorafenib is a multikinase inhibitor that has received increasing attention due to its high efficacy in hepatocellular carcinoma treatment. However, its poor pharmacokinetic properties (limited water solubility, rapid elimination, and metabolism) still represent major bottlenecks that need to be ove...

Full description

Bibliographic Details
Main Authors: Adrian Bartos, Ioana Iancu, Lidia Ciobanu, Anca Onaciu, Cristian Moldovan, Alin Moldovan, Radu Cristian Moldovan, Adrian Bogdan Tigu, Gabriela Fabiola Stiufiuc, Valentin Toma, Cornel Iancu, Nadim Al Hajjar, Rares Ionut Stiufiuc
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Nanomaterials
Subjects:
hybrid liposomal nanoformulation
hepatoma therapy
Raman analysis
Online Access:https://www.mdpi.com/2079-4991/12/16/2833

Internet

https://www.mdpi.com/2079-4991/12/16/2833

Similar Items